Mölnlycke Health Care US, LLC introduces Biogel PI Pro-Fit®, a non-latex surgical glove designed to allow for a new level of comfort during surgery while reducing employee and patient health risks and costs.
Designed with a biomechanically optimized former to help prevent hand fatigue during surgery and a synthetic material that feels just as good as latex, 94 percent of surgeons surveyed rated Biogel PI (non-latex) as good as or better than Biogel Latex.
According to a recent study, there are approximately 17 operating room (OR) backtable teardowns per year on average per facility due to undetected latex allergies in patients. With Biogel PI Pro-Fit®, the OR teardown cost risk associated with glove-related patient latex allergies is eliminated.
Additionally over time, healthcare workers can develop latex sensitivity, which can average costs up to $218,000 per employee to treat their latex allergy. Biogel non-latex gloves reduce the risk of workers compensation claims and lost productivity due to staff with glove-related latex allergies being unable to work.
Biogel gloves have statistically significant fewer observed failures than other glove brands, reducing the exposure to pathogens and associated costs of treatment. In an independent observational in-use comparison study, non-Biogel gloves were 3.5 times as likely to fail in-use compared to Biogel surgical gloves.
Source: Mölnlycke Health Care US, LLC Â
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.